Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population

Journal of Hypertension

Volumn 16, Issue 5, 1998, Pages 577-583

  Antikainen, Riitta ^a   Jousilahti, Pekka ^b   Tuomilehto, Jaakko ^b  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Middle aged population; Mortality; Prospective study; Systolic blood pressure

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CORONARY RISK; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; MORTALITY; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; STROKE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

EID: 0031961190     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816050-00004     Document Type: Article

References (32)

1. Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension. The Framingham study. Circulation 1980; 61:1179-1182.
2. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol 1971; 27:335-346.
3. Mann SJ. Systolic hypertension in the elderly. Pathophysiology and management. Arch Intern Med 1992; 152:1977-1984.
4. Colandrea MA, Friedman GD, Nichaman MZ, Lynd CN. Systolic hypertension in the elderly. An epidemiological assessment. Circulation 1970; 41:239-245.
5. Curb JD, Borhani O, Entwisle G, Tung B, Kass E, Schnaper H, et al. Isolated systolic hypertension in 14 communities. Am J Epidemiol 1985; 121:362-370.
6. Rutan GH, Kuller LH, Neaton JD, Wentworth DN, McDonald RH, McFate Smith W. et al. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation 1988; 77:504-514.
7. Van den Ban GC, Kampman E, Schouten EG, Kok FJ, van der Heide RM, van der Heide-Wessel C. Isolated systolic hypertension in Dutch middle aged and all-cause mortality: a 25-year prospective study. Int J Epidemiol 1989; 18:95-99.
8. Wilking SVB, Belanger A, Kannel WB, D'Agostino RB. Determinants of isolated systolic hypertension. JAMA 1988; 260:3451-3455.
9. Staessen J, Amery A, Fagard R. Isolated systolic hypertension in the elderly [review]. J Hypertens 1990; 8:393-405.
10. Pajak A, Kuulasmaa K, Tuomilehto J, Ruokokoski E. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. The WHO MONICA Project. World Health Stat Q 1988; 41:115-140.
11. Tuomilehto J, Salonen JT, Nissinen A. Isolated systolic hypertension and its relationship to the risk of myocardial infarction, cerebrovascular disease and death in a middle-aged population. Eur Heart J 1984; 5:739-744.
12. Uemura K, Piša Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q 1988; 41:155-178.
13. Puska P, Tuomilehto J, Salonen J, Nissinen A, Virtamo J, Björkquist S, et al. Community control of cardiovascular disease -The North Karelia Project: evaluation of a comprehensive community programme for control of cardiovascular diseases in 1972-1977 in North Karelia. Copenhagen, Denmark: World Health Organization/European Region; 1981.
14. Puska P, Nissinen A, Tuomilehto J, Salonen JT, Koskela K, McAlister A, et al. The community based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia Project. Annu Rev Public Health 1985; 6:147-193.
15. Cox DR. Regression models and life tables. J R Stat Soc [B] 1972; 34:187-220.
16. Petrovitch H, Curb JD, Bloom-Marcus E. Isolated systolic hypertension and risk of stroke in Japanese-American men. Stroke 1995; 26:25-29.
17. Forette F, de la Fuente X, Golmard J-L, Henry J-F, Hervy M-P. The prognostic significance of isolated systolic hypertension in the elderly. Results of ten year longitudinal survey. Clin Exp Hypertens [A] 1982; 4:1177-1191.
18. Nielsen WB, Vestbo J, Jensen GB. Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an unexploited source of cardiovascular prevention: a prospective population based study. J Hum Hypertens 1995; 9:175-180.
19. Shekelle RB, Ostfeld AM, Klawans HL. Hypertension and the risk of stroke in an elderly population. Stroke 1974; 5:71-75.
20. Weijenberg MP, Feskens E, Kromhout D. Blood pressure and isolated systolic hypertension and the risk of coronary heart disease and mortality in elderly men, J Hypertens 1996; 14:1159-1166.
21. Garland C, Barrett-Connor E, Suarez L, Criqui MH. Isolated systolic hypertension and mortality after age 60 years. A prospective population-based study. Am J Epidermiol 1983; 118:365-376.
22. Safar ME, Cloarec-Branchard L, London GM. Arterial alterations in hypertension with a disproportionate elevation in systolic over diastolic blood pressure. J Hypertens 1996; 14 (suppl 2):S103-S110.
23. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P. Changes in risk factors explain changes in mortality from ischemic heart disease in Finland. BMJ 1994; 309:23-27.
24. Stamler J, Neaton JD, Wenthworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989; 13 (suppl I):I2-I12.
25. Sagie A, Larson MG, Levy D. The natural history of borderline isolated systolic hypertension. N Engl J Med 1993; 329:1912-1917.
26. O'Donnell CJ, Ridker PM, Glynn RJ, Berger K, Ajani U, Manson JE, et al. Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation 1997; 95:1132-1137.
27. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P. Neaton J. et al. Blood pressure, stroke, and coronary heart disease. Part 1. prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
28. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265:3255-3264.
29. Staessen JA, Fagard R. Thijs L, Celis H, Arabidze GG, Birkenhäger WH, et al. for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350:757-764.
30. Cutler JA, Follman D, Elliot P, Sun I. An overview of randomized trials of sodium reduction and blood pressure. Hypertension 1991; 17 (suppl I): I27-I33.
31. Alderman M. Non-pharmacological treatment of hypertension. Lancet 1994; 344:307-311.
32. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the trials of hypertension prevention, phase I. JAMA 1992; 267:1213-1220.